Exosome-Based Delivery of miR-124 in a Huntington’s Disease Model

Objective Huntington’s disease (HD) is a genetic neurodegenerative disease that is caused by abnormal CAG expansion. Altered microRNA (miRNA) expression also causes abnormal gene regulation in this neurodegenerative disease. The delivery of abnormally downregulated miRNAs might restore normal gene r...

Full description

Saved in:
Bibliographic Details
Published in:Journal of movement disorders 2017, 10(1), , pp.45-52
Main Authors: Lee, Soon-Tae, Im, Wooseok, Ban, Jae-Jun, Lee, Mijung, Jung, Keun-Hwa, Lee, Sang Kun, Chu, Kon, Kim, Manho
Format: Article
Language:English
Subjects:
exosome
Huntington’s disease
microRNA
miR-124
Original
R6/2
신경과학
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective Huntington’s disease (HD) is a genetic neurodegenerative disease that is caused by abnormal CAG expansion. Altered microRNA (miRNA) expression also causes abnormal gene regulation in this neurodegenerative disease. The delivery of abnormally downregulated miRNAs might restore normal gene regulation and have a therapeutic effect. Methods We developed an exosome-based delivery method to treat this neurodegenerative disease. miR-124, one of the key miRNAs that is repressed in HD, was stably overexpressed in a stable cell line. Exosomes were then harvested from these cells using an optimized protocol. The exosomes (Exo-124) exhibited a high level of miR-124 expression and were taken up by recipient cells. Results When Exo-124 was injected into the striatum of R6/2 transgenic HD mice, expression of the target gene, RE1-Silencing Transcription Factor, was reduced. However, Exo-124 treatment did not produce significant behavioral improvement. Conclusion This study serves as a proof of concept for exosome-based delivery of miRNA in neurodegenerative diseases.
ISSN:2005-940X
2093-4939
DOI:10.14802/jmd.16054